Plain-English translation of NCT06571669 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing sacral neuromodulation — a device that's implanted to stimulate nerves in your lower spine — to help reduce the urgent bowel symptoms that come with ulcerative colitis. Everyone in the study receives this device (there's no comparison group taking something else). Researchers will track whether your bowel urgency improves over the first 12 weeks and continue monitoring you for a full year.
Ulcerative colitis often causes severe and unpredictable bowel urgency that significantly affects quality of life. This trial exists to see whether this nerve-stimulation treatment can offer relief when other options haven't worked well enough.
You likely qualify if…
You likely don't qualify if…
You will receive an implanted sacral neuromodulation device through a surgical procedure. After implantation, you'll have regular follow-up visits to assess how well the device is working and to monitor your symptoms. Your bowel urgency will be measured using a standard rating scale at 12 weeks (the main focus) and throughout the year-long study period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States